Prolonged course of toxic shock syndrome associated with methicillin-resistant Staphylococcus aureus enterotoxins G and I

International Journal of Infectious Diseases

Volumn 5, Issue 3, 2001, Pages 163-166

  Meyer, Richard D ^a,b   Monday, Steven R ^c,e   Bohach, Gregory A ^d   Schlievert, Patrick M ^a,b  

^a Northridge Hospital Medical Center   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF IDAHO   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIBODY; CD4 ANTIGEN; CD8 ANTIGEN; CEFAZOLIN; CEFTAZIDIME; CHLORHEXIDINE; CIPROFLOXACIN; CORTICOSTEROID; CREATININE; DOPAMINE; ENTEROTOXIN; FLUCONAZOLE; GENTAMICIN; IMIPENEM; IMMUNOGLOBULIN; MEROPENEM; METICILLIN; MINOCYCLINE; NORADRENALIN; PHENYLEPHRINE; PSEUDOMONIC ACID; RIFAMPICIN; STAPHYLOCOCCUS ENTEROTOXIN; TETRACYCLINE; VANCOMYCIN;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BLOOD CULTURE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DEBRIDEMENT; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPOTENSION; LEUKOCYTOSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; POLYMERASE CHAIN REACTION; TOXIC SHOCK SYNDROME;

ENTEROTOXINS; FEMALE; HUMANS; METHICILLIN RESISTANCE; MIDDLE AGED; SHOCK, SEPTIC; STAPHYLOCOCCAL INFECTIONS; SUPERANTIGENS;

EID: 0035570075     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1201-9712(01)90093-1     Document Type: Article

References (23)

1. Nonmenstrual toxic shock syndrome: New insights into diagnosis, pathogenesis, and treatment
2. Toxic shock syndrome
3. Toxic shock syndrome
4. The staphylococcal enterotoxins and their relatives
5. Detection of staphylococcal enterotoxin B among toxic shock syndrome (TSS)- and non-TSS-associated Staphylococcus aureus isolates
6. Characterization and biological properties of a new staphylococcal exotoxin
7. Involvement of enterotoxins G and I in staphylococcal toxic shock syndrome and staphylococcal scarlet fever
8. Enterotoxins and toxic-shock syndrome toxin-1 non-enteric staphylococcal disease
9. Use of multiplex PCR to detect classical and newly described pyrogenic toxin genes in staphylococcal isolates
10. Immunochemical assays for toxic shock syndrome toxin-1
11. Clinical aspects and spectrum of illness of toxic shock syndrome: Overview
12. Clinical spectrum of non-menstrual toxic shock syndrome (TSS): Comparison with menstrual TSS by multivariate discriminant analyses
13. Exanthematous disease induced by toxic shock syndrome toxin-1 in the early neonatal period
14. A recalcitrant, erythematous, desquamating disorder associated with toxin-producing staphylococci in patients with AIDS
15. Activation of the cytokine network in a patient with AIDS and the recalcitrant erythematous desquamating disorder
16. Folliculitis decalvans and human T-cell lymphotropic virus type-I-associated myelopathy/tropical spastic paraparesis
17. Kawasaki syndrome-like illness associated with infection caused by enterotoxin B-secreting Staphylococcus aureus
18. Toxin involvement in staphylococcal scalded skin syndrome
19. Identification and characterization of staphylococcal enterotoxin types G and I from Staphylococcus aureus
20. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome: A comparative observational study
21. Intravenous immunoglobulin contains antibodies inhibitory to activation of T-cells by staphylococcal superantigens
22. Protection against Staphylococcus aureus sepsis by vaccination with recombinant staphylococcal enterotoxin A devoid of superantigenicity
23. Toxic shock syndrome in the United States: Surveillance update, 1979-1996